ʻO COVID-19 Antigen Rapid Test Kit (Colloidal Gold)
Nā palena
1. Hoʻohana wale ʻia kēia reagent no ka maʻi in vitro.
2. This reagent is only used to find human nasal swabs/oropharyngeal swabs specimen. He hewa paha nā hopena o nā hōʻailona ʻē aʻe.
3. Hoʻohana wale ʻia kēia reagent no ka ʻike qualitative a ʻaʻole hiki ke ʻike i ke kiʻekiʻe o ka novel corona virus antigen i ka specimen.
ʻO 4. ʻO kēia reagent he mea hana diagnostic auxiliary wale nō. Inā maikaʻi ka hopena, ʻōlelo ʻia e hoʻohana i nā ʻano hana ʻē aʻe no ka nānā hou ʻana i ka manawa a e lanakila ka maʻi o ke kauka.
5. Inā maikaʻi ʻole ka hopena hōʻike a hoʻomau nā hōʻailona maʻi. Manaʻo ʻia e hana hou i ka laʻana a hoʻohana i nā ʻano hoʻokolohua ʻē aʻe no ka hoʻāʻo ʻana. ʻAʻole hiki i kahi hopena maikaʻi ʻole ke pale i ka hiki ke ʻike a i ʻole ka maʻi me ka maʻi SARS-CoV-2 i kēlā me kēia manawa.
6. ʻO nā hopena ho'āʻo o nā pahu ho'āʻo no nā kauka kauka wale nō, aʻaʻole pono e hoʻohanaʻia ma keʻano he kumu hoʻokahi no ka maʻi maʻi. Pono e noʻonoʻo ʻia ka hoʻokele lapaʻau o nā maʻi i hui pū ʻia me kā lākou mau hōʻailona/hōʻailona, ka mōʻaukala olakino, nā hoʻokolohua ʻē aʻe a me nā pane lapaʻau, etc.
7. Ma muli o ka palena o ke ʻano reagent ʻike, ʻoi aku ka haʻahaʻa o ka palena o ka ʻike ʻana o kēia reagent ma mua o ka nucleic acid reagents. No laila, pono e nānā pono nā limahana hōʻike i nā hopena maikaʻi ʻole a pono e hui pū i nā hopena hōʻike ʻē aʻe e hana i kahi hoʻoholo piha. Manaʻo ʻia e hoʻohana i ka hoʻāʻo nucleic acid a i ʻole ka hoʻokaʻawale ʻana i nā virus a me nā ʻano ʻike moʻomeheu e nānā i nā hopena maikaʻi ʻole i kānalua.
8. ʻAʻole hoʻokaʻawale nā hopena hoʻokolohua maikaʻi i ka co-infection me nā pathogens ʻē aʻe.
9. Hiki ke loaʻa nā hopena maikaʻi ʻole inā ʻoi aku ka haʻahaʻa o ka pae antigen SARS-CoV-2 i ka laʻana ma mua o ka palena ʻike o ka pahu a i ʻole ka hōʻiliʻili ʻana a me ka lawe ʻana i nā mea hoʻohālike. No laila, inā ʻaʻole maikaʻi nā hopena hōʻike, ʻaʻole hiki ke hoʻokuʻu ʻia ka hiki ʻana o ka maʻi SARS-CoV-2.
10. ʻO nā waiwai wānana maikaʻi a maikaʻi ʻole e hilinaʻi nui ʻia i nā helu prevalence. ʻOi aku ka maikaʻi o nā hopena hoʻāʻo maikaʻi e hōʻike i nā hopena maikaʻi ʻole i nā manawa liʻiliʻi / ʻaʻohe hana SARS-CoV-2 ke haʻahaʻa ka maʻi maʻi. ʻOi aku ka nui o nā hopena hoʻāʻo maikaʻi ʻole ke kiʻekiʻe ka piʻi ʻana o ka maʻi i hoʻokumu ʻia e SARS-CoV-2.
11.Analysis o ka hiki ke loaʻa nā hopena maikaʻi ʻole:
(1) ʻOhi hōʻailona kūpono ʻole, ka lawe ʻana a me ka hoʻoponopono ʻana, ka helu virus haʻahaʻa i ka hāpana, ʻaʻohe laʻana hou a i ʻole ka hoʻoheheʻe ʻana a me ka hoʻoheheʻe ʻana o ka hāpana hiki ke alakaʻi i nā hopena maikaʻi ʻole.
(2) ʻO ka hoʻololi ʻana o ka gene viral hiki ke alakaʻi i nā loli i nā mea hoʻoholo antigenic, e alakaʻi i nā hopena maikaʻi ʻole.
(3) ʻAʻole paʻa loa ka noiʻi ʻana i ka SARS-CoV-2; hiki i ka ma'i ke ho'ololi a ho'oulu i nā 'oko'a no ka manawa hō'ailona maika'i loa (virus titer peak) a me ka wahi ho'ohālike. No laila, no ka mea maʻi hoʻokahi, hiki iā mākou ke hōʻiliʻili i nā laʻana mai nā wahi he nui a i ʻole ka hahai ʻana no nā manawa he nui e hōʻemi i ka hopena o nā hopena maikaʻi ʻole.
12. ʻAʻole hiki i nā antibodies monoclonal ke ʻike, a i ʻole ka ʻike me ka liʻiliʻi o ka naʻau, nā maʻi maʻi SARS-CoV-2 i hoʻololi i nā hoʻololi liʻiliʻi amino acid ma ka ʻāpana epitope.
